Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

SYNTAX score II - Authors' reply.

Farooq V, van Klaveren D, Steyerberg EW, Serruys PW.

Lancet. 2013 Jun 1;381(9881):1899-900. doi: 10.1016/S0140-6736(13)61152-6. No abstract available.

PMID:
23725720
2.

SYNTAX score II.

Tajik P, Oude Rengerink K, Mol BW, Bossuyt PM.

Lancet. 2013 Jun 1;381(9881):1899. doi: 10.1016/S0140-6736(13)61151-4. No abstract available.

PMID:
23725721
3.

ACP Journal Club. SYNTAX score II predicted mortality after PCI or CABG in complex CAD better than SYNTAX score.

Bach RG.

Ann Intern Med. 2013 Jul 16;159(2):JC5. doi: 10.7326/0003-4819-159-2-201307160-02005. No abstract available.

PMID:
23856703
4.

Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.

Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, Kappetein AP, Colombo A, Holmes DR Jr, Mack M, Feldman T, Morice MC, Ståhle E, Onuma Y, Morel MA, Garcia-Garcia HM, van Es GA, Dawkins KD, Mohr FW, Serruys PW.

Lancet. 2013 Feb 23;381(9867):639-50. doi: 10.1016/S0140-6736(13)60108-7.

PMID:
23439103
5.

The SYNTAX score and SYNTAX-based clinical risk scores.

Farooq V, Brugaletta S, Serruys PW.

Semin Thorac Cardiovasc Surg. 2011 Summer;23(2):99-105. doi: 10.1053/j.semtcvs.2011.08.001. Review.

PMID:
22041038
6.

CABG or stents in coronary artery disease: end of the debate?

Taggart DP.

Lancet. 2013 Feb 23;381(9867):605-7. doi: 10.1016/S0140-6736(13)60258-5. No abstract available.

PMID:
23439089
7.

The SYNTAX score: usefulness, limitations, and future directions.

Chakrabarti AK, Gibson CM.

J Invasive Cardiol. 2011 Dec;23(12):511-2. Review. No abstract available.

8.

Does percutaneous coronary intervention compromise the outcome of subsequent coronary artery bypass grafting?

Mack M.

JACC Cardiovasc Interv. 2009 Aug;2(8):765-6. doi: 10.1016/j.jcin.2009.06.005. No abstract available.

9.

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR Jr, Morel MA, Van Dyck N, Houle VM, Dawkins KD, Serruys PW.

Lancet. 2013 Feb 23;381(9867):629-38. doi: 10.1016/S0140-6736(13)60141-5.

PMID:
23439102
10.

CABG vs angioplasty in kidney disease.

[No authors listed]

Harv Heart Lett. 2012 Dec;23(4):8. No abstract available.

PMID:
23476948
11.

Is the SYNTAX score a predictor of long-term outcome after coronary artery bypass surgery?

Holzhey DM, Luduena MM, Rastan A, Jacobs S, Walther T, Mohr FW, Falk V.

Heart Surg Forum. 2010 Jun;13(3):E143-8. doi: 10.1532/HSF98.20091157.

PMID:
20534412
12.

Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.

Head SJ, Holmes DR Jr, Mack MJ, Serruys PW, Mohr FW, Morice MC, Colombo A, Kappetein AP; SYNTAX Investigators.

JACC Cardiovasc Interv. 2012 Jun;5(6):618-25. doi: 10.1016/j.jcin.2012.02.013.

13.

Validating the EXCEL hypothesis: a propensity score matched 3-year comparison of percutaneous coronary intervention versus coronary artery bypass graft in left main patients with SYNTAX score ≤32.

Capodanno D, Caggegi A, Capranzano P, Cincotta G, Miano M, Barrano G, Monaco S, Calvo F, Tamburino C.

Catheter Cardiovasc Interv. 2011 Jun 1;77(7):936-43. doi: 10.1002/ccd.22992. Epub 2011 May 5.

PMID:
21547994
14.

The Gordian knot of revascularization for multivessel coronary artery disease.

Takagi H, Manabe H, Umemoto T.

J Thorac Cardiovasc Surg. 2011 Jul;142(1):241-2; author reply 242-3. doi: 10.1016/j.jtcvs.2011.02.042. No abstract available.

15.

How much delta does your kappa make to my patients? Putting the SYNTAX score into clinical context.

Morrison DA.

Catheter Cardiovasc Interv. 2010 May 1;75(6):953-6. doi: 10.1002/ccd.22579. No abstract available.

PMID:
20432401
16.

Class I indications for coronary artery bypass graft surgery: what is the appropriate therapy for patients with multivessel coronary disease?

Dean LS.

JACC Cardiovasc Interv. 2009 Jul;2(7):622-3. doi: 10.1016/j.jcin.2009.05.009. No abstract available.

17.

Transradial access: just do it!

Mann T.

JACC Cardiovasc Interv. 2009 Nov;2(11):1065-6. doi: 10.1016/j.jcin.2009.08.023. No abstract available.

18.

Does specific interventional risk scoring better predict mortality than comorbidity in nonagenerians undergoing coronary angioplasty?

Ormerod JO, Ramcharitar S.

Cardiovasc Revasc Med. 2014 Jun;15(4):258-60. doi: 10.1016/j.carrev.2014.02.008. Epub 2014 Mar 6.

PMID:
24685014
19.

A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.

Serruys PW, Farooq V, Vranckx P, Girasis C, Brugaletta S, Garcia-Garcia HM, Holmes DR Jr, Kappetein AP, Mack MJ, Feldman T, Morice MC, Ståhle E, James S, Colombo A, Pereda P, Huang J, Morel MA, Van Es GA, Dawkins KD, Mohr FW, Steyerberg EW.

JACC Cardiovasc Interv. 2012 Jun;5(6):606-17. doi: 10.1016/j.jcin.2012.03.016.

20.

Supplemental Content

Support Center